|
Jan 22
|
Gilead Sciences, Citi, Digital World Acquisition: Top Stocks
|
|
Jan 22
|
Gilead Stock Plunges On Disappointing Cancer Drug Study
|
|
Jan 22
|
Why Is HIV Drug Giant Gilead Stock Falling Monday?
|
|
Jan 22
|
Gilead Stock Tumbles on Cancer Drug Disappointment
|
|
Jan 22
|
Gilead Sinks After Lung Cancer Drug Fails to Improve Survival
|
|
Jan 22
|
Gilead Provides Update on Phase 3 EVOKE-01 Study
|
|
Jan 22
|
Gilead says Trodelvy fails to meet primary goal in 2nd-line lung cancer trial
|
|
Jan 22
|
Gilead drops 11% after lung cancer drug trial fails, analysts say stock is 'overreacting'
|
|
Jan 22
|
Gilead ADC medicine misses goal in closely watched lung cancer study
|
|
Jan 18
|
Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs
|
|
Jan 18
|
Gilead Sciences Inc CFO Andrew Dickinson Sells 5,000 Shares
|
|
Jan 17
|
Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts
|
|
Jan 16
|
Gilead Sciences with Emma's Story: Self-Advocacy in Breast Cancer
|
|
Jan 12
|
Gilead Sciences Inc's Chief Commercial Officer Johanna Mercier Sells 8,242 Shares
|
|
Jan 11
|
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
Gilead’s Quiet Revolution: Is GILD the Next Big Stock to Soar?
|
|
Jan 10
|
Gilead Pays Tribute to Patient Advocacy Work: Cara’s Story
|
|
Dec 29
|
Gilead Sciences (GILD) Stock Moves -0.16%: What You Should Know
|
|
Dec 28
|
Here's Why Gilead Sciences (NASDAQ:GILD) Can Manage Its Debt Responsibly
|